Medican Enterprises Inc. logo

Medican Enterprises Inc. (MDCN)

Market Closed
10 Aug, 20:00
OTC PINK OTC PINK
$
0. 00
0
0%
$
2.88M Market Cap
- P/E Ratio
- Div Yield
4M Volume
0 Eps
$ 0
Previous Close
Add Transaction
Day Range
0 0
Year Range
0 0
Want to track MDCN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

MDCN closed yesterday higher at $0, an increase of 0% from Friday's close, completing a monthly increase of 0% or $0. Over the past 12 months, MDCN stock gained 0%.
MDCN is not paying dividends to its shareholders.
The last earnings report, released on Apr 15, 2015, missed the consensus estimates by -1.83%. On average, the company has fell short of earnings expectations by -3.4282%, based on the last three reports.
Medican Enterprises Inc. has completed 4 stock splits, with the recent split occurring on Apr 20, 2015.
The company's stock is traded on one exchange.

MDCN Chart

People also search for

Decker Manufacturing Corporation
$ 57.01
0%
Cannabix Technologies Inc.
$ 0.39
+1.8421%
VicapSys Life Sciences Inc.
$ 1.45
0%
Nuo Therapeutics Inc.
$ 0.85
0%
Quantumzyme Corp.
$ 0.8
+33.3333%

Medican Enterprises Inc. (MDCN) FAQ

What is the stock price today?

The current price is $0.00.

On which exchange is it traded?

Medican Enterprises Inc. is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is MDCN.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 2.88M.

Has Medican Enterprises Inc. ever had a stock split?

Medican Enterprises Inc. had 4 splits and the recent split was on Apr 20, 2015.

Medican Enterprises Inc. Profile

Health Care Technology Industry
Healthcare Sector
Mitchell Xavier CEO
OTC PINK Exchange
58464T202 CUSIP
US Country
3 Employees
- Last Dividend
20 Apr 2015 Last Split
- IPO Date

Overview

Medican Enterprises, Inc. is a dynamic bio-pharmaceutical company established in 1988, with its headquarters located in Las Vegas, Nevada. It is primarily engaged in exploring and seizing lucrative business avenues within the burgeoning sectors of medical and recreational marijuana. The company's strategy encompasses a comprehensive approach, focusing on the cultivation, marketing, research and development, training, distribution, and retail sales of medical and recreational marijuana, primarily targeting markets in the United States and Canada.

Products and Services

  • Growing: Medican Enterprises, Inc. ventures into the cultivation of high-quality medical and recreational marijuana, leveraging advanced agricultural techniques and sustainable practices to ensure the production of premium-grade cannabis.
  • Marketing: The company employs strategic marketing initiatives aimed at promoting their cannabis products effectively across different channels, ensuring visibility and reach within their target markets in the US and Canada.
  • Research and Development: At its core, Medican is committed to innovation through ongoing research and development efforts. These efforts focus on enhancing the quality, potency, and variety of cannabis strains, alongside exploring new applications of marijuana in medicine.
  • Training: Understanding the importance of knowledge in the rapidly evolving cannabis industry, Medican offers comprehensive training programs. These programs are designed to educate growers, distributors, and retailers about the latest trends, regulations, and techniques in the cannabis sector.
  • Distribution: The company has established a robust distribution network that ensures the efficient and wide-spread distribution of their products to various medicinal and recreational outlets across their operational territories.
  • Retail Sale: Medican Enterprises, Inc. extends its footprint to the retail sector by offering medical and recreational marijuana through its dispensaries. These retail points are designed to provide customers with a wide selection of cannabis products in a safe and welcoming environment.

Contact Information

Address: 6320 Canoga Avenue
Phone: 800-416-8802